尿三聚氰胺水平与慢性肾脏病进展相关
这项前瞻性队列研究纳入293例eGFR≥30 ml/min/1.73 m²的早期CKD患者,基线尿三聚氰胺/肌酐比值中位数为0.97 μg/mmol。中位随访7.0年,最高三分位组(≥2.70 μg/mmol)相较最低三分位组(0.02-0.58 μg/mmol)血清肌酐翻倍风险显著升高(HR 2.30,95%CI 1.25-4.23,P<0.01),eGFR年下降>3 ml/min/1.73 m²及2年内eGFR下降30%也呈剂量-反应关系。
要点
- 早期CKD患者尿三聚氰胺水平与肾功能恶化显著相关。
- 最高三分位组血清肌酐翻倍风险是最低组的2.30倍。
- eGFR快速下降结局同样呈现显著剂量-反应关系。
核心结论
- 在早期CKD患者中,尿三聚氰胺水平与肾功能恶化显著相关。
研究设计与样本
- 前瞻性队列研究,2006-2010年纳入eGFR≥30 ml/min/1.73 m²患者共293例。
- 基线用液相色谱-串联质谱测定尿三聚氰胺/尿肌酐比值,随访至2016年12月。
主要发现
- 中位尿三聚氰胺/肌酐比值为0.97 μg/mmol(四分位距0.43-2.08)。
- 中位随访7.0年,80例(27%)出现血清肌酐翻倍。
- 最高三分位组(≥2.70 μg/mmol)血清肌酐翻倍风险为最低三分位组(0.02-0.58 μg/mmol)的2.30倍(95%CI 1.25-4.23,P<0.01)。
- eGFR年下降>3 ml/min/1.73 m²及2年内eGFR下降30%也呈显著剂量-反应关系。
临床怎么用
- 对早期CKD患者可关注环境三聚氰胺暴露,作为肾功能恶化风险评估的潜在参考。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: CKD is a global public health problem. Some cross-sectional studies have associated environmental melamine exposure with kidney diseases, but evidence is limited. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: We conducted this prospective cohort study to enroll patients with eGFR≥30 ml/min per 1.73 m2 in 2006-2010. Urinary corrected melamine levels (ratio of urinary melamine to urinary creatinine) were measured by liquid chromatography/tandem mass spectrometry at enrollment. Kidney outcomes included doubling of serum creatinine levels, eGFR decline >3 ml/min per 1.73 m2 per year, and 30% decline in eGFR in the first 2 years. Subjects were followed until targeted kidney outcomes, cancer, death, last contact, or the end of observation in December 2016. RESULTS: In a total of 293 subjects, the median urinary corrected melamine level was 0.97 (interquartile range, 0.43-2.08) μg/mmol. Over a median follow-up period of 7.0 years, serum creatinine levels doubled in 80 subjects (27%). Subjects in the highest tertile of urinary melamine level 12.70 μg/mmol) had a 2.30 (95% confidence interval, 1.25 to 4.23; P<0.01) hazard risk for doubling of serum creatinine compared with those in the lowest tertile (0.02-0.58 μg/mmol). Similar significant dose-response results were found in eGFR decline >3 ml/min per 1.73 m2 per year and 30% decline in eGFR in the first 2 years. CONCLUSIONS: Urinary melamine level is significantly associated with kidney function deterioration in patients with early-stage CKD.
引用
- Tsai YC, Wu CF, Liu CC, et al. Urinary Melamine Levels and Progression of CKD. Clin J Am Soc Nephrol. 2019. PMID: 31337620. doi:10.2215/CJN.01740219
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。